Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study
Authors:
Open Access
- 2 September 2024
- Vol. 42 (24) , 126252
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Abnormal uterine bleeding diagnoses and care following COVID-19 vaccinationAmerican Journal of Obstetrics and Gynecology, 2024
- Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccinationVaccine, 2023
- Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in NorwayVaccine, 2022
- Vaccine-induced immune thrombotic thrombocytopeniaBest Practice & Research Clinical Haematology, 2022
- Abnormal Uterine Bleeding Among COVID-19 Vaccinated and Recovered Women: a National SurveyReproductive Sciences, 2022
- No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya studyPapillomavirus Research, 2018
- Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in FranceRevue D'Épidémiologie Et de Santé Publique, 2017
- Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported casesImmunologic Research, 2014
- Six Persistent Research MisconceptionsJournal of General Internal Medicine, 2014
- Variance estimators for attributable fraction estimates consistent in both large strata and sparse dataStatistics in Medicine, 1987